Review Article| Volume 33, ISSUE 4, P875-880, December 2013

Download started.


Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gall Bladder, and Extrahepatic Biliary Tract

Published:October 11, 2013DOI:


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Cancer Facts and Figures 2012. Available at: Accessed September 7, 2013.

      2. Dragovich T, Harris JE. Pancreatic cancer clinical presentation, MedScape Reference Web site. Available at: Accessed September 7, 2013.

        • Iacobuzio-Donahue C.A.
        • Song J.
        • Parmiagiani G.
        • et al.
        Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors.
        Clin Cancer Res. 2004; 10: 1597-1604
        • Wilentz R.E.
        • Su G.H.
        • Dai J.L.
        • et al.
        Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation.
        Am J Pathol. 2000; 156: 37-43
        • Odze R.D.
        • Goldblum J.R.
        Surgical pathology of the GI tract, liver, biliary tract, and pancreas.
        Saunders/Elsevier, Philadelphia2009
        • Lemoine N.R.
        • Jain S.
        • Hughes C.M.
        • et al.
        Ki-ras oncogene activation in preinvasive pancreatic cancer.
        Gastroenterology. 1992; 102: 230-236
        • Moskaluk C.A.
        • Hruban R.H.
        • Kern S.E.
        p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.
        Cancer Res. 1997; 57: 2140-2143
        • Biankin A.V.
        • Biankin S.A.
        • Kench J.G.
        • et al.
        Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
        Gut. 2002; 50: 861-868
        • Iacobuzio-Donahue C.A.
        • Klimstra D.S.
        • Adsay N.V.
        • et al.
        Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
        Am J Pathol. 2000; 157: 755-761
        • Hoorens A.
        • Lemoine N.R.
        • McLellan E.
        • et al.
        Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.
        Am J Pathol. 1993; 143: 685-698
        • Görtz B.
        • Roth J.
        • Krähenmann A.
        • et al.
        Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.
        Am J Pathol. 1999; 154: 429-436
        • Hessman O.
        • Lindberg D.
        • Einarsson A.
        • et al.
        Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
        Genes Chromosomes Cancer. 1999; 26: 258-264
        • Komminoth P.
        Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
        Diagn Mol Pathol. 1999; 8: 107-112
        • Moore P.S.
        • Missiaglia E.
        • Antonello D.
        • et al.
        Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL.
        Genes Chromosomes Cancer. 2001; 32: 177-181
        • Abraham S.C.
        • Klimstra D.S.
        • Wilentz R.E.
        • et al.
        Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.
        Am J Pathol. 2002; 160: 1361-1369
        • Moore P.S.
        • Orlandini S.
        • Zamboni G.
        • et al.
        Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
        Br J Cancer. 2001; 84: 253-262
        • Howe J.R.
        • Klimstra D.S.
        • Cordon-Cardo C.
        • et al.
        K-ras mutation in adenomas and carcinomas of the ampulla of vater.
        Clin Cancer Res. 1997; 3: 129-133
        • Achille A.
        • Scupoli M.T.
        • Magalini A.R.
        • et al.
        APC gene mutations and allelic losses in sporadic ampullary tumours: evidence of genetic difference from tumours associated with familial adenomatous polyposis.
        Int J Cancer. 1996; 68: 305-312
        • Bayraktar S.
        • Rocha Lima C.M.
        Emerging cell-cycle inhibitors for pancreatic cancer therapy.
        Expert Opin Emerg Drugs. 2012; 17: 571-582
        • Zucman-Rossi J.
        • Jeannot E.
        • Nhieu J.T.
        • et al.
        Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
        Hepatology. 2006; 43: 515-524
        • Bioulac-Sage P.
        • Rebouissou S.
        • Sa Cunha A.
        • et al.
        Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver.
        Gastroenterology. 2005; 128: 1211-1218
        • Paradis V.
        • Benzekri A.
        • Dargère D.
        • et al.
        Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.
        Gastroenterology. 2004; 126: 1323-1329
        • Paradis V.
        • Bièche I.
        • Dargère D.
        • et al.
        A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.
        Gastroenterology. 2003; 124: 651-659
        • Sugimachi K.
        • Taguchi K.
        • Aishima S.
        • et al.
        Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
        Mod Pathol. 2001; 14: 900-905
        • Ashida K.
        • Terada T.
        • Kitamura Y.
        • et al.
        Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
        Hepatology. 1998; 27: 974-982
        • Taguchi K.
        • Aishima S.
        • Asayama Y.
        • et al.
        The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma.
        Hepatology. 2001; 33: 1118-1123
        • Ito Y.
        • Takeda T.
        • Sasaki Y.
        • et al.
        Bcl-2 expression in cholangiocellular carcinoma is inversely correlated with biologically aggressive phenotypes.
        Oncology. 2000; 59: 63-67
        • Volkan Adsay N.
        • Klimstra D.S.
        Benign and malignant tumors of the gallbladder and extrahepatic biliary tract.
        in: Odze R.D. Goldblum J.R. Surgical pathology of the GI tract, liver, biliary tract and pancreas. 2nd edition. Saunders/Elsevier, Philadelphia2009
        • Chang H.J.
        • Jee C.D.
        • Kim W.H.
        Mutation and altered expression of beta-catenin during gallbladder carcinogenesis.
        Am J Surg Pathol. 2002; 26: 758-766
        • Chang H.J.
        • Kim S.W.
        • Kim Y.T.
        • et al.
        Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
        Mod Pathol. 1999; 12: 763-769
        • Wistuba I.I.
        • Ashfaq R.
        • Maitra A.
        • et al.
        Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
        Am J Pathol. 2002; 160: 2073-2079
        • Batheja N.
        • Suriawinata A.
        • Saxena R.
        • et al.
        Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
        Mod Pathol. 2000; 13: 1265-1268
        • Argani P.
        • Shaukat A.
        • Kaushal M.
        • et al.
        Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
        Cancer. 2001; 91: 1332-1341
        • Nagahashi M.
        • Ajioka Y.
        • Lang I.
        • et al.
        Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary.
        World J Gastroenterol. 2008; 14: 70-75